Colitis severity was dramatically decreased in PAD4-/- mice after DSS treatment, which displayed a smaller weight loss (Figure 2A), lower DAI score (Figure 2B) and minimal lethality (Supplementary Figure S3), compared with their wild-type controls. The gene discussed is PADI4; the disease is colitis.